ProfileGDS4718 / 201974_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 46% 49% 45% 48% 47% 47% 50% 46% 48% 49% 47% 49% 51% 49% 48% 48% 48% 46% 47% 50% 53% 46% 48% 47% 46% 47% 51% 46% 46% 51% 48% 47% 50% 46% 48% 45% 49% 49% 49% 44% 47% 51% 45% 46% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.3076446
GSM549102patient 115, normal, homogenized [OPG study]5.4998449
GSM549104patient 119, normal, homogenized [OPG study]5.2547445
GSM549108patient 138, normal, homogenized [OPG study]5.4730748
GSM549119patient 077, normal, homogenized [OPG study]5.3357147
GSM549133patient 032, cancer, homogenized [OPG study]5.2853347
GSM549139patient 042, cancer, homogenized [OPG study]5.4732350
GSM549099patient 107, normal, homogenized [OPG study]5.3234946
GSM549109patient 139, normal, homogenized [OPG study]5.4232748
GSM549110patient 046, normal, homogenized [OPG study]5.4371649
GSM549114patient 063, normal, homogenized [OPG study]5.3062847
GSM549122patient 082, normal, homogenized [OPG study]5.4865249
GSM549134patient 033, cancer, homogenized [OPG study]5.5510451
GSM549136patient 036, cancer, homogenized [OPG study]5.4215849
GSM549140patient 044, cancer, homogenized [OPG study]5.3680648
GSM549111patient 047, normal, homogenized [OPG study]5.3658348
GSM549113patient 057, normal, homogenized [OPG study]5.3210448
GSM549132patient 031, cancer, homogenized [OPG study]5.3081846
GSM549137patient 038, cancer, homogenized [OPG study]5.3505247
GSM549142patient 047, cancer, homogenized [OPG study]5.6301450
GSM549100patient 110, normal, homogenized [OPG study]5.6681553
GSM549107patient 135, normal, homogenized [OPG study]5.2419146
GSM549115patient 068, normal, homogenized [OPG study]5.3449648
GSM549116patient 072, normal, homogenized [OPG study]5.3240847
GSM549120patient 078, normal, homogenized [OPG study]5.2741346
GSM549131patient 030, cancer, homogenized [OPG study]5.2743747
GSM549118patient 074, normal, homogenized [OPG study]5.5601951
GSM549129patient 027, cancer, homogenized [OPG study]5.3386646
GSM549123patient 088, normal, homogenized [OPG study]5.2992246
GSM549124patient 006, cancer, homogenized [OPG study]5.6093351
GSM549126patient 015, cancer, homogenized [OPG study]5.3816548
GSM549128patient 025, cancer, homogenized [OPG study]5.3555947
GSM549103patient 117, normal, homogenized [OPG study]5.5834150
GSM549117patient 073, normal, homogenized [OPG study]5.2755446
GSM549138patient 041, cancer, homogenized [OPG study]5.4149348
GSM549141patient 045, cancer, homogenized [OPG study]5.1812645
GSM549130patient 028, cancer, homogenized [OPG study]5.4508949
GSM549101patient 111, normal, homogenized [OPG study]5.5047249
GSM549105patient 128, normal, homogenized [OPG study]5.4776349
GSM549106patient 134, normal, homogenized [OPG study]5.1585444
GSM549112patient 048, normal, homogenized [OPG study]5.3530347
GSM549125patient 011, cancer, homogenized [OPG study]5.5903651
GSM549127patient 024, cancer, homogenized [OPG study]5.2580345
GSM549135patient 035, cancer, homogenized [OPG study]5.254746